The Medina Group welcomes three Shreyer’s scholars to the lab: Matthew Aronson, Samuel Ajamu and Agustey Mongia! Matthew is developing peptide-lipid nanoparticles for targeted cancer therapy. Samuel’s work seeks to develop novel peptide-based MRI imaging agents. Agustey is interested in exploring new biomaterials that integrate with host commensal flora.
Good luck Matthew, Samuel and Agustey!
